1072 SECTION IX Pediatric Critical Care Hematology and Oncology multiple organ failure The Thrombocytopenia Associated Multiple Organ Failure Network Prospective Experience Crit Care Med 2019; 47(3) e[.]
1072 S E C T I O N I X Pediatric Critical Care: Hematology and Oncology multiple organ failure: The Thrombocytopenia-Associated Multiple Organ Failure Network Prospective Experience Crit Care Med 2019; 47(3):e173-e181 Gando S, Otomo Y Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock Crit Care 2015;19:72 Gulati D, Novak A, Stanworth SJ Common haemostasis issues in major bleeding and critical illness Clin Med (Lond) 2018;18(4): 320-323 Iba T, Levy H Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis J Thromb Haemost 2018;16:23-241 Levi M, Scully M, Singer M The role of ADAMTS-13 in the coagulopathy of sepsis J Thromb Haemost 2018;16(4):646-651 Pluta J, Trzebicki J Thrombocytopenia: the most frequent haemostatic disorder in the ICU Anaesthesiol Intensive Ther 2019;51(1):56-63 Saner FH, Bezinover D Assessment and management of coagulopathy in critically-ill patients with liver failure Curr Opin Crit Care 2019; 25(2):179-186 van der Poll T, Parker RI Platelet activation and endothelial cell dysfunction Crit Care Clin 2020;36:233–253 Walborn A, Rondina M, Mosier M, Fareed J, Hoppensteadt D Endothelial dysfunction is associated with mortality and severity of coagulopathy in patients with sepsis and disseminated intravascular coagulation Clin Appl Thromb Hemost 2019;25:1076029619852163 The full reference list for this chapter is available at ExpertConsult.com e1 References Gulati D, Novak A, Stanworth SJ Common haemostasis issues in major bleeding and critical illness Clin Med (Lond) 2018;18(4): 320-323 Levi M, van der Poll T Coagulation and sepsis Thromb Res 2017; 149:38-44 Gando S, Otomo Y Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock Crit Care 2015;19:72 Gale AJ Current understanding of hemostasis Toxicol Pathol 2011;39:373-380 Iba T, Levy H Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis J Thromb Haemost 2018;16:23-241 Golebiewska EM, Poole AW Platelet secretion: From haemostasis to wound healing and beyond Blood Rev 2015;29(3):153-162 Wang Y, Gallant RC, Ni H Extracellular matrix proteins in the regulation of thrombus formation Curr Opin Hematol 2016;23(3):280-287 Levi M, Scully M, Singer M The role of ADAMTS-13 in the coagulopathy of sepsis J Thromb Haemost 2018;16(4):646-651 Iba T, Levy JH Derangement of the endothelial glycocalyx in sepsis J Thromb Haemost 2019;17(2):283-294 10 Pendurthi UR, Rao LVM Endothelial cell protein C receptordependent signaling Curr Opin Hematol 2018;25(3):219-226 11 Witkowski M, Landmesser U, Rauch U Tissue factor as a link between inflammation and coagulation Trends Cardiovasc Med 2016; 26(4):297-303 12 Esmon CT The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness Crit Care 2001;5(2):S7-S12 13 Tipoe TL, Wu WKK, Chung L, et al Plasminogen activator inhibitor for predicting sepsis severity and mortality outcomes: a systematic review and meta-analysis Front Immunol 2018;9:1218 14 Van De Craen B, Declerck PJ, Gils A The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1inhibition in vivo Thromb Res 2012;130(4):576-585 15 Hayakawa M, Sawamura A, Gando S, et al A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis Thromb Res 2012;130(6):906-913 16 Jenne CN, Kubes P Platelets in inflammation and infection Platelets 2015;26(4):286-292 17 Samuels JM, Moore HB, Moore EE Coagulopathy in severe sepsis: interconnectivity of coagulation and the immune system Surg Infect (Larchmt) 2018;19(2):208-215 18 Delano MJ, Ward PA The immune system’s role in sepsis progression, resolution, and long-term outcome Immunol Rev 2016;274(1): 330-353 19 Hayakawa M, Ono K A summary of the Japan septic disseminated intravascular coagulation study Acute Med Surg 2018;5:123-128 20 Yatabe T, Inoue S, Sakamoto S, et al The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis Thromb Res 2018;171:136-142 21 Bereziuk OM, Mazur JV, Berko GK, et al Primary and secondary thrombophili: pathogenesis, clinical presentation, approaches to thrombotic complications prevention and treatment Wiad Lek 2019;72(5 cz 1):908-913 22 Ashraf N, Visweshwar N, Jaglal M, et al Evolving paradigm in thrombophilia screening Blood Coagul Fibrinolysis 2019;30(5): 249-252 23 Gatt A, Chen D, Pruthi RK, et al From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective Semin Thromb Hemost 2014;40(8):845-851 24 Moorehead PC, Barrowman NJ, Cyr J, et al A Prospective study of the association between clinically significant bleeding in PICU patients and thrombocytopenia or prolonged coagulation times Pediatr Crit Care Med 2017;18(10):e455-e462 25 Sandrasegaran K, Thayalan N, Thavanesan R, et al Risk factors for bleeding after liver biopsy Abdom Radiol (NY) 2016;41(4): 643-649 26 Russell L, Madsen MB, Dahl M, et al Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients Acta Anaesthesiol Scand 2018; 62(2):196-206 27 Tamim H, Habbal M, Saliba A, et al Preoperative INR and postoperative major bleeding and mortality: A retrospective cohort study J Thromb Thrombolysis 2016;41(2):301-311 28 Bonar RA, Lippi G, Favaloro EJ Overview of hemostasis and thrombosis and contribution of laboratory testing to diagnosis and management of hemostasis and thrombosis disorders Methods Mol Biol 2017;1646:3-27 29 Pal S, Curley A, Stanworth SJ Interpretation of clotting tests in the neonate Arch Dis Child Fetal Neonatal Ed 2015;100(3):F270-F274 30 Castanon A, Pierre G, Willis R, et al Performance evaluation and clinical associations of immunoassays that detect antibodies to negatively charged phospholipids other than cardiolipin Am J Clin Pathol 2018;149(5):401-411 31 Park HS, Gu JY, Jung HS, Kim HK Thrombotic risk of non-criteria anti-phospholipid antibodies measured by line immunoassay: superiority of anti-phosphatidylserine and anti-phosphatidic acid antibodies Clin Lab 2019;65(3) 32 Hvas AM, Favaloro EJ Platelet function testing in pediatric patients Expert Rev Hematol 2017;10(4):281-288 33 Hayward CPM, Moffat KA, Brunet J, et al Update on diagnostic testing for platelet function disorders: What is practical and useful? Int J Lab Hematol 2019;41(suppl 1):26-32 34 Swami A, Kaur V von Willebrand disease: a concise review and update for the practicing physician Clin Appl Thromb Hemost 2017;23(8):900-910 35 Levi M, Scully M How I treat disseminated intravascular coagulation Blood 2018;131(8):845-854 36 Colling ME, Bendapudi PK Purpura fulminans: mechanism and management of dysregulated hemostasis Transfus Med Rev 2018;32(2):69-76 37 Rajagopal R, Thachil J, Monagle P Disseminated intravascular coagulation in paediatrics Arch Dis Child 2017;102(2):187-193 38 Walborn A, Rondina M, Mosier M, et al Endothelial dysfunction is associated with mortality and severity of coagulopathy in patients with sepsis and disseminated intravascular coagulation Clin Appl Thromb Hemost 2019;25:1076029619852163 39 Patel P, Walborn A, Rondina M, et al Markers of inflammation and infection in sepsis and disseminated intravascular coagulation Clin Appl Thromb Hemost 2019;25:1076029619843338 40 Johansson PI, Stensballe J, Ostrowski SR Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism Crit Care 2017;21(1):25 [Review Erratum in: Crit Care 2017;21(1):187.] 41 Soundar EP, Jariwala P, Nguyen TC, et al Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients Am J Clin Pathol 2013;139(6):812-816 42 Iba T, Watanabe E, Umemura Y, et al Sepsis-associated disseminated intravascular coagulation and its differential diagnoses J Intensive Care 2019;7:32 43 Wada H, Matsumoto T, Yamashita Y Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines J Intensive Care 2014;2(1):15 44 Koyama K, Madoiwa S, Nunomiya S, et al Combination of thrombinantithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study Crit Care 2014;18(1):R13 45 Singh N, Pati HP, Tyagi S, Upadhyay AD, Saxena R Evaluation of the diagnostic performance of fibrin monomer in comparison to dDimer in patients with overt and nonovert disseminated intravascular coagulation Clin Appl Thromb Hemost 2017;23(5):460-465 e2 46 Huq MA, Takeyama N, Harada M, et al 4G/5G polymorphism of the plasminogen activator type-1 gene is associated with multiple organ dysfunction in critically ill patients Acta Haematol 2012;127: 72-80 47 Scully M, Levi M How we manage haemostasis during sepsis Br J Haematol 2019;185(2):209-218 48 Simpson E, Lin Y, Stanworth S, et al Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia Cochrane Database Syst Rev 2012;(3):CD005011 49 Mesleh Shayeb A, Su Y, Kang G, et al Efficacy and safety of recombinant activated factor VII off-label use in a pediatric hematology/ oncology cohort J Pediatr Hematol Oncol 2019;41(2):e72-e78 50 Tanaka K, Takeba J, Matsumoto H, et al Anticoagulation therapy using rh-thrombomodulin and/or antithrombin III agent is associated with reduction in in-hospital mortality in septic disseminated intravascular coagulation: a nationwide registry study Shock 2019; 51(6):713-717 51 Masias C, Vasu S, Cataland SR None of the above: thrombotic microangiopathy beyond TTP and HUS Blood 2017;129(21):28572863 52 Trachtman H HUS and TTP in Children Pediatr Clin North Am 2013;60(6):1513-1526 53 Jokiranta TS HUS and atypical HUS Blood 2017;129(21):28472856 54 Pluta J, Trzebicki J Thrombocytopenia: the most frequent haemostatic disorder in the ICU Anaesthesiol Intensive Ther 2019;51(1): 56-63 55 Nguyen TC, Cruz MA, Carcillo JA Thrombocytopenia-associated multiple organ failure and acute kidney injury Crit Care Clin 2015;31(4):661-674 56 Fortenberry JD, Nguyen T, Grunwell JR, et al Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the thrombocytopenia-associated multiple organ failure network prospective experience Crit Care Med 2019;47(3):e173-e181 57 Tripodi A Hemostasis in acute and chronic liver disease Semin Liver Dis 2017;37(1):28-32 58 Saner FH, Bezinover D Assessment and management of coagulopathy in critically-ill patients with liver failure Curr Opin Crit Care 2019;25(2):179-186 59 Harrison MF The misunderstood coagulopathy of liver disease: a review for the acute setting West J Emerg Med 2018;19(5): 863-871 60 Zakeri N, Tsochatzis EA Bleeding risk with invasive procedures in patients with cirrhosis and coagulopathy Curr Gastroenterol Rep 2017;19(9):45 61 Davis JPE, Northup PG, Caldwell SH, Intagliata NM Viscoelastic testing in liver disease Ann Hepatol 2018;17(2):205-213 62 Roberts LN, Bernal W Management of bleeding and thrombosis in critically ill patients with liver disease Semin Thromb Hemost 2015;41(5):520-526 63 Chakraverty R, Davidson S, Peggs K, et al The incidence and cause of coagulopathies in an intensive care population Br J Haematol 1996;93(2):460-463 64 Dahlberg S, Schurgers L, Schött U, Kander T Vitamin K deficiency in critical ill patients; a prospective observational study J Crit Care 2019;49:105-109 65 Cugno M, Gualtierotti R, Tedeschi A, Meroni PL Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy Autoimmun Rev 2014;13(1):40-48 doi:10.1016/j.autrev.2013.08.001 Epub 2013 Aug 14 [Review Erratum in: Autoimmun Rev 2015; 14(7):650.] 66 Ieko M, Yoshida M, Naito S, et al Lupus anticoagulant-hypoprothrombinemia syndrome and similar diseases: experiences at a single center in Japan Int J Hematol 2019;110(2):197-204 67 Lee N, Kim JE, Yoo HJ, et al Acquired dysfibrinogenemia caused by autoantibody inhibiting fibrin polymerization in a patient with melas syndrome and bleeding tendency Ann Clin Lab Sci 2016; 46(6):696-700 68 Simmons JW, Powell MF Acute traumatic coagulopathy: pathophysiology and resuscitation Br J Anaesth 2016;117(suppl 3):iii31iii43 [Review Erratum in: Br J Anaesth 2017;119(6):1245.] 69 Perkins JG, Cap AP, Spinella PC, et al Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME) Transfusion 2011;51(2): 242-252 70 Maw G, Furyk C Pediatric massive transfusion: a systematic review Pediatr Emerg Care 2018;34(8):594-598 71 Kamyszek RW, Leraas HJ, Reed C, et al Massive transfusion in the pediatric population: A systematic review and summary of bestevidence practice strategies J Trauma Acute Care Surg 2019;86(4): 744-754 72 Aubron C, Aries P, Le Niger C, et al How clinicians can minimize transfusion-related adverse events? Transfus Clin Biol 2018;25(4): 257-261 73 Zeeshan M, Hamidi M, Feinstein AJ, et al Four-factor prothrombin complex concentrate is associated with improved survival in traumarelated hemorrhage: a nationwide propensity-matched analysis J Trauma Acute Care Surg 2019;87(2):274-281 74 Wikkelsø A, Wetterslev J, Møller AM, Afshari A.Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding Cochrane Database Syst Rev 2016;(8):CD007871 75 Abohelaika S, Wynne H, Avery P, et al Effect of genetic and patient factors on warfarin pharmacodynamics following warfarinwithdrawal: implications for patients undergoing surgery Thromb Res 2018;171:167-170 76 Kakagia DD, Papanas N, Karadimas E, Polychronidis A Warfarininduced skin necrosis Ann Dermatol 2014;26(1):96-98 77 Raimondi P, Hylek EM, Aronis KN Reversal agents for oral antiplatelet and anticoagulant treatment during bleeding events: current strategies Curr Pharm Des 2017;23(9):1406-1423 78 Onishi A, St Ange K, Dordick JS, Linhardt RJ Heparin and anticoagulation Front Biosci (Landmark Ed) 2016;21:1372-1392 79 Hirsh J, Bauer KA, Donati MB, et al Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 2008;133(suppl 6):141S-159S [Erratum in: Chest 2008;134(2):473.] 80 Carr JA, Silverman N The heparin-protamine interaction: a review J Cardiovasc Surg (Torino) 1999;40:659-666 81 Sokolowska E, Kalaska B, Miklosz J, Mogielnicki A The toxicology of heparin reversal with protamine: past, present and future Expert Opin Drug Metab Toxicol 2016;12(8):897-909 82 Radulescu VC Anticoagulation therapy in children Semin Thromb Hemost 2017;43(8):877-885 83 Douxfils J, Mani H, Minet V, et al Non-VKA oral anticoagulants: accurate measurement of plasma drug concentrations Biomed Res Int 2015;2015:345138 84 Chang SH, Chou IJ, Yeh YH, et al Association between use of nonvitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation JAMA 2017;318(13):1250-1259 85 Dabi A, Koutrouvelis AP Reversal strategies for intracranial hemorrhage related to direct oral anticoagulant medications Crit Care Res Pract 2018;2018:4907164 86 Zarychanski R, Houston DS Assessing thrombocytopenia in the intensive care unit: the past, present, and future Hematology Am Soc Hematol Educ Program 2017;2017(1):660-666 87 Claushuis TA, van Vught LA, Scicluna BP, et al Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients Blood 2016;127(24):3062-3072 88 Kim WH, Park JB, Jung CW, Kim GS Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura Platelets 2015;26(1):38-42 89 Newland A, Lee EJ, McDonald V, Bussel JB Fostamatinib for persistent/chronic adult immune thrombocytopenia Immunotherapy 2018;10(1):9-25 e3 90 Reese JA, Nguyen LP, Buchanan GR, et al Drug-induced thrombocytopenia in children Pediatr Blood Cancer 2013;60(12):19751981 91 Kumar A, Mhaskar R, Grossman BJ, et al Platelet transfusion: a systematic review of the clinical evidence Transfusion 2015;55(5): 1116-1127; quiz 1115 92 Schmidt AE, Henrichs KF, Kirkley SA, et al Prophylactic preprocedure platelet transfusion is associated with increased risk of thrombosis and mortality Am J Clin Pathol 2017;149(1):87-94 93 Curley A, Stanworth SJ, Willoughby K, et al Randomized trial of platelet-transfusion thresholds in neonates N Engl J Med 2019; 380(3):242-251 94 Pidcoke HF, Spinella PC, Ramasubramanian AK, et al Refrigerated platelets for the treatment of acute bleeding: a review of the literature and reexamination of current standards Shock 2014; 41(suppl 1):51-53 95 Cuker A, Gimotty PA, Crowther MA, Warkentin TE Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis Blood 2012;120:41604167 96 Risch L, Huber AR, Schmugge M Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children Thromb Res 2006;118:123-135 97 Junqueira DR, Zorzela LM, Perini E Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients Cochrane Database Syst Rev 2017;4:CD007557 98 East JM, Cserti-Gazdewich CM, Granton JT Heparin-induced thrombocytopenia in the critically ill patient Chest 2018;154(3): 678-690 99 Skelley JW, Kyle JA, Roberts RA Novel oral anticoagulants for heparin-induced thrombocytopenia J Thromb Thrombolysis 2016; 42(2):172-178 100 White GC II Congenital and acquired platelet disorders: current dilemmas and treatment strategies Semin Hematol 2006;43(1 suppl 1):S37-S41 101 Sloan SR, Parker RI Current status of platelet transfusion in pediatric patients Transfus Med Rev 2016;30(4):230-234 102 Estcourt LJ, Stanworth SJ, Doree C, et al Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation Cochrane Database Syst Rev 2015;(11): CD010983 103 Napolitano G, Iacobellis A, Merla A, et al Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia Eur J Intern Med 2017;38:79-82 104 Arstum ZA, Huynh TT, Huang SY, Pisimisis GT Risk of bleeding after ultrasound-guided jugular central venous catheter insertion in severely thrombocytopenic oncologic patients Am J Surg 2019; 217(1):133-137 105 Zeidler K, Arn K, Senn O, et al Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia Transfusion 2011;51(11):22692276 106 James AH, Eikenboom J, Federici AB State of the art: von Willebrand disease Haemophilia 2016;22(suppl 5):54-59 107 Chima RS, Hanson SJ Venous thromboembolism in critical illness and trauma: pediatric perspectives Front Pediatr 2017;5:47 108 Neshat-Vahid S, Pierce R, Hersey D, et al Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis J Thromb Haemost 2016;14(9):17491758 109 Kenet G, Limperger V, Shneyder M, et al Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years? Blood Cells Mol Dis 2017;67:18-22 110 van der Poll T, Parker RI Platelet activation and endothelial cell dysfunction Crit Care Clin 2019; in press 111 Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, et al Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians J Thromb Thrombolysis 2017;44(3): 377-385 112 Perdomo J, Leung HHL, Ahmadi Z, et al Neutrophil activation and NETosis are the major drivers of thrombosis in heparininduced thrombocytopenia Nat Commun 2019;10(1):1322 e4 Abstract: Critically ill children are at risk for developing secondary issues of unbalanced hemostasis manifested by either bleeding or unwanted clotting The intensivist must be aware of this possibility and take appropriate measures to address these issues before they become major factors in patient management and outcome To accomplish this goal, the intensivist must first be aware of what can happen and have sufficient understanding of the elements involved in normal hemostasis to be able to formulate an initial diagnostic and therapeutic plan, and to know when consultation with hematology is warranted Key words: coagulopathy, critically ill, bleeding, anticoagulation ... intensivist must be aware of this possibility and take appropriate measures to address these issues before they become major factors in patient management and outcome To accomplish this goal, the intensivist... in thrombophilia screening Blood Coagul Fibrinolysis 2019;30(5): 249-252 23 Gatt A, Chen D, Pruthi RK, et al From vitamin K antagonists to liver international normalized ratio: a historical journey... 2015;41(5):520-526 63 Chakraverty R, Davidson S, Peggs K, et al The incidence and cause of coagulopathies in an intensive care population Br J Haematol 1996;93(2):460-463 64 Dahlberg S, Schurgers